Hepatocellular carcinoma treated with sorafenib: authors' reply

被引：0
|
作者：
Peck-Radosavljevic, M. [1 ]
Pinter, M. [1 ]
Sieghart, W. [1 ]
机构：
[1] Med Univ Vienna, Dept Gastroenterol & Hepatol, Vienna, Austria
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2011年 / 34卷 / 11-12期
关键词：
D O I：
10.1111/j.1365-2036.2011.04889.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1348 / 1349
页数：2
相关论文
共 50 条
  • [41] Changes of Cytokines in Cirrhosis Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib
    Nagai, Hidenari
    Mukozu, Takanori
    Matui, Daigo
    Ogino, Yu
    Kanekawa, Takenori
    Kogame, Michio
    Takayama, Ryuji
    Kanayama, Masahiro
    Wakui, Noritaka
    Shinohara, Mie
    Shinohara, Masao
    Ishii, Koji
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    GASTROENTEROLOGY, 2012, 142 (05) : S979 - S979
  • [42] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with Sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Biondetti, P.
    Pellicelli, A. M.
    Sangiovanni, A.
    Lampertico, P.
    Marignani, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S207 - S208
  • [43] Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
    Inghilesi, Andrea L.
    Gallori, Donatella
    Antonuzzo, Lorenzo
    Forte, Paolo
    Tomcikova, Daniela
    Arena, Umberto
    Colagrande, Stefano
    Pradella, Silvia
    Fani, Bernardo
    Gianni, Elena
    Boni, Luca
    Laffi, Giacomo
    Di Costanzo, Francesco
    Marra, Fabio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (03) : 786 - 794
  • [44] The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib
    Sarpel, Umut
    Spivack, John H.
    Berger, Yaniv
    Heskel, Marina
    Aycart, Samantha N.
    Sweeney, Robert
    Edwards, Martin P.
    Labow, Daniel M.
    Kim, Edward
    HPB, 2016, 18 (05) : 411 - 418
  • [45] Targeted genome profiling in patients with advanced hepatocellular carcinoma treated with sorafenib
    Kang, Wonseok
    Kim, Kyung
    Lee, Joon Hyeok
    Lim, Ho Yeong
    Park, Woong-Yang
    Lee, Jeeyun
    Paik, Yong Han
    CANCER RESEARCH, 2017, 77
  • [46] Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma
    Soria, Anna
    Calvo, Mariona
    Casas, Meritxell
    Vidales, Zara
    Munoz-Martinez, Sergio
    Sapena, Victor
    Puigvehi, Marc
    Canillas, Lidia
    Guardeno, Raquel
    Gallego, Adolfo
    Minguez, Beatriz
    Horta, Diana
    Clos, Ariadna
    Montoliu, Silvia
    Roget, Merce
    Reig, Maria
    Vergara, Mercedes
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Nivolumab plus Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib
    Tsang, Josephine
    Wong, Jeffrey Sum Lung
    Kwok, Gerry Gin Wai
    Li, Bryan Cho Wing
    Leung, Roland
    Chiu, Joanne
    Cheung, Tan to
    Yau, Thomas
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (06) : 589 - 598
  • [48] Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenib
    Wada, Y.
    Takami, Y.
    Matsushima, H.
    Ryu, T.
    Mikagi, K.
    Saitsu, H.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S630 - S631
  • [49] Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib
    Otsuka, Taiga
    Eguchi, Yuichiro
    Kawazoe, Seiji
    Yanagita, Kimihiko
    Ario, Keisuke
    Kitahara, Kenji
    Kawasoe, Hiroaki
    Kato, Hiroyuki
    Mizuta, Toshihiko
    HEPATOLOGY RESEARCH, 2012, 42 (09) : 879 - 886
  • [50] Survival outcomes of metastatic/unresectable hepatocellular carcinoma patients treated with sorafenib
    Chantharusamee, Jomjit
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345